Unknown

Dataset Information

0

DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma.


ABSTRACT: BACKGROUND:Hepatocellular carcinoma (HCC) is one of the major causes of tumor-related morbidity and mortality worldwide. Accumulating evidence has revealed that aberrant expression of crucial cancer-related genes contributes to hepatocellular carcinogenesis. This study aimed to characterize the biological role of DEP domain containing 1 (DEPDC1), a novel cancer-related gene, in HCC and illuminate the potential molecular mechanisms involved. MATERIALS AND METHODS:Quantitative real-time PCR (qRT-PCR), Western blotting and immunohistochemical (IHC) staining were used to characterize the expression patterns of DEPDC1 in tumorous tissues and adjacent normal tissues. Kaplan-Meier survival analysis was launched to evaluate the relationship between DEPDC1 expression and overall survival. CCK8 assay, colony formation and flow cytometry were performed to investigate the effects of DEPDC1 on HCC cell viability, clonogenic capability and cell apoptosis. Murine xenograft models were established to determine the effect of DEPDC1 on tumor growth in vivo SP600125, a JNK specific inhibitor, was applied to carriy out mechanistic studies. RESULTS:DEPDC1 was significantly up-regulated in HCC tissues compared with para-cancerous tissues. Besides, patients with high DEPDC1 expression experienced a significantly shorter overall survival. Functional investigations demonstrated that DEPDC1 overexpression facilitated HCC cell proliferation and suppressed cell apoptosis, whereas DEPDC1 depletion inhibited cell proliferation and promoted cell apoptosis. Furthermore, DEPDC1 ablation suppressed tumorigenecity of HCC cells in murine xenograft models. Mechanistic studies uncovered that JNK signaling pathway mediated the promoting effects of DEPDC1 on HCC cell viability and chemotherapy resistance. CONCLUSION:Collectively, our data may provide some evidence for DEPDC1 as a candidate therapeutic target for HCC.

SUBMITTER: Zhou C 

PROVIDER: S-EPMC6620382 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma.

Zhou Chao C   Wang Pu P   Tu Mengtian M   Huang Yi Y   Xiong Fei F   Wu Yue Y  

Bioscience reports 20190710 7


<h4>Background</h4>Hepatocellular carcinoma (HCC) is one of the major causes of tumor-related morbidity and mortality worldwide. Accumulating evidence has revealed that aberrant expression of crucial cancer-related genes contributes to hepatocellular carcinogenesis. This study aimed to characterize the biological role of DEP domain containing 1 (DEPDC1), a novel cancer-related gene, in HCC and illuminate the potential molecular mechanisms involved.<h4>Materials and methods</h4>Quantitative real-  ...[more]

Similar Datasets

| S-EPMC6667871 | biostudies-literature
| S-EPMC5639348 | biostudies-literature
| S-EPMC4882485 | biostudies-other
| S-EPMC7062894 | biostudies-literature
| S-EPMC7039039 | biostudies-literature
| S-EPMC9834419 | biostudies-literature
| S-EPMC3928300 | biostudies-literature
| S-EPMC7206140 | biostudies-literature
| S-EPMC7759511 | biostudies-literature
| S-EPMC10583008 | biostudies-literature